Companies specialising in artificial intelligence (AI) in healthcare are in “rude health” and are set for exponential growth over the next five years, according to a new report.
Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.
An algorithm could be used by an NHS hospital in England to predict which people may experience a mental health crisis based on their mobile phone use, according to a press report.